secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2023-09-12T23:59:59+00:00
Accession:  0001104659-23-099831
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance Biopharma furnishes investor slide deck for H.C. Wainwright conference
--------------------------------------------------------------------------------

- Management team participating in fireside chat at H.C. Wainwright 25th Annual Global Investment Conference on Sep 12, 2023.
- Slide presentation furnished as Exhibit 99.1 under Regulation FD; no specific financial or operational updates disclosed in the filing.
- The filing does not contain earnings figures, guidance changes, or corporate developments beyond the conference schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923099831/0001104659-23-099831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923099831/tm2325915d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-099831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer